HomeCompareJTAIW vs MRK

JTAIW vs MRK: Dividend Comparison 2026

JTAIW yields 4474.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JTAIW wins by $21185982677218.59M in total portfolio value
10 years
JTAIW
JTAIW
● Live price
4474.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21185982677218.65M
Annual income
$20,293,751,012,595,216,000.00
Full JTAIW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JTAIW vs MRK

📍 JTAIW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJTAIWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JTAIW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JTAIW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JTAIW
Annual income on $10K today (after 15% tax)
$380,313.20/yr
After 10yr DRIP, annual income (after tax)
$17,249,688,360,705,933,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JTAIW beats the other by $17,249,688,360,705,925,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JTAIW + MRK for your $10,000?

JTAIW: 50%MRK: 50%
100% MRK50/50100% JTAIW
Portfolio after 10yr
$10592991338609.35M
Annual income
$10,146,875,506,297,612,000.00/yr
Blended yield
95.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JTAIW
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JTAIW buys
0
MRK buys
0
No recent congressional trades found for JTAIW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJTAIWMRK
Forward yield4474.27%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$21185982677218.65M$56.8K
Annual income after 10y$20,293,751,012,595,216,000.00$9,798.13
Total dividends collected$21125382446220.09M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JTAIW vs MRK ($10,000, DRIP)

YearJTAIW PortfolioJTAIW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$458,127$447,427.29$11,206$366.19+$446.9KJTAIW
2$19,647,080$19,156,883.61$12,650$502.35+$19.63MJTAIW
3$788,830,895$767,808,519.27$14,407$694.19+$788.82MJTAIW
4$29,654,831,364$28,810,782,306.25$16,585$967.82+$29654.81MJTAIW
5$1,043,969,097,359$1,012,238,427,799.76$19,342$1,363.89+$1043969.08MJTAIW
6$34,420,650,434,166$33,303,603,499,992.53$22,913$1,947.19+$34420650.41MJTAIW
7$1,063,046,326,636,291$1,026,216,230,671,733.50$27,662$2,823.89+$1063046326.61MJTAIW
8$30,757,675,476,619,980$29,620,215,907,119,150.00$34,159$4,173.35+$30757675476.59MJTAIW
9$833,861,368,806,947,000$800,950,656,046,963,500.00$43,337$6,308.80+$833861368806.90MJTAIW
10$21,185,982,677,218,650,000$20,293,751,012,595,216,000.00$56,776$9,798.13+$21185982677218.59MJTAIW

JTAIW vs MRK: Complete Analysis 2026

JTAIWStock

Jet.AI Inc. primarily engages in the development and operation of private aviation platforms. The company operates CharterGPT, a booking platform that functions as a prospecting and quoting platform to arrange private jet travel with its aircrafts and third-party carriers. It also provides Reroute AI software that recycles aircraft waiting to return to base into prospective new charter bookings to destinations within specific distances; and DynoFlight, a software application programming interface (API), which enables aircraft operators to track and estimate emissions, and purchase carbon offset credits. In addition, the company offers Flight Club API, an aviation software, that enables FAA Part 135 operators to function simultaneously under FAA Part 380, which permits sale of private jet service by the seat instead of by whole aircraft. Further, it offers aircraft charter, management, and brokerage services. The company was founded in 2018 and is headquartered in Las Vegas, Nevada.

Full JTAIW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JTAIW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JTAIW vs SCHDJTAIW vs JEPIJTAIW vs OJTAIW vs KOJTAIW vs MAINJTAIW vs JNJJTAIW vs ABBVJTAIW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.